Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2010 014 230.2 |
96 | EP file number | EAKZ | 10 73 4541.5 |
86 | WO file number | WAKZ | PCT/GB2010/051066 |
97 | EP publication number | EPN | 2448637 |
87 | WO publication number | WPN | 2011001169 |
54 | Designation/title | TI | VERWENDUNG EINES PHYTOCANNABINOIDS ODER EINER KOMBINATION AUS PHYTOCANNABINOIDEN ZUR BEHANDLUNG VON EPILEPSIE |
51 | IPC main class | ICM (ICMV) | A61P 25/08 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/352 (2006.01) |
22 | DE application date | DAT | Jun 29, 2010 |
96 | EP application date | EAT | Jun 29, 2010 |
86 | WO application date | WAT | Jun 29, 2010 |
43 | Date of first publication | OT | Jan 6, 2011 |
| Date of publication of grant | PET | Mar 12, 2014 |
71/73 | Applicant/owner | INH | Jazz Pharmaceuticals Research UK Limited, Sittingbourne, Kent, GB |
72 | Inventor | IN | WRIGHT, Stephen, Salisbury SP4 0JQ, GB; WILLIAMS, Claire, Reading RG6 6AP, GB; GUY, Geoffrey, Salisbury SP4 0JQ, GB; KIKUCHI, Tetsuro, Osaka 5410045, JP; STEPHENS, Gary, Reading RG6 6AP, GB; WHALLEY, Ben, Reading RG6 6AP, GB |
74 | Representative | VTR | HGF Europe LLP, 81673 München, DE |
| Address for service | | HGF Europe LLP, 81673 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0911580 Jul 3, 2009
|
| Due date | FT FG | Jun 30, 2026 Annual fee for the 17th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002448637 Searchable text:
EP000002448637 Original document:
EP000002448637B1 Searchable text:
EP000002448637B1 Original document:
EP000002448637B2 Searchable text:
EP000002448637B2 Original document:
WO002011001169 Searchable text:
WO002011001169 |
43 | Date of first publication | EVT | Jan 6, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Jun 22, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 16, 2025 (Show all update days)(Hide all update days)- Jul 16, 2025
- Applicant/owner: changed
- Procedures: New applicant/owner details, New applicant/owner details, 15.07.2025: new
- Jul 9, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 12.03.2014: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 12.03.2014: deleted
- Apr 10, 2025
- Jun 22, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 28, 2023 |
| Issue number | HN | 23 |
| Year | PJ | 2023 |
| Publication date | VT | Jun 7, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | GW Pharma Ltd., Histon, Cambridge, GB |
71/73 | Previous applicant/owner | INHF | GW Pharma Ltd., Salisbury, Wiltshire, GB, Otsuka Pharmaceutical Co., Ltd., 101 Tokio/Tokyo, Chiyoda-ku, JP |
| Date of update of the procedure | REGT | Jun 7, 2023 |